Rapid Mycoplasma Detection Techniques for Facilitating Quality in Low-Volume T-Cell Therapies

Q: What does this research mean for the field?

Rapid detection techniques for Mycoplasma improve quality assurance in low-volume T-cell therapies. Novelty: ClaimNovelty.METHODOLOGICAL. Consensus alignment: ConsensusAlignment.NEUTRAL.

Min Le

doi:10.5731/pdajpst.2026.26121

January 1, 2026PDA Journal of Pharmaceutical Science and Technology

Rapid Mycoplasma Detection Techniques for Facilitating Quality in Low-Volume T-Cell Therapies

View Full Paper

Ask AI

Bookmark

Share

Key Points

The study aims to evaluate rapid detection techniques for mycoplasma in low-volume T-cell therapies to ensure quality control.
Processed samples using Applied Biosystems™ PrepSEQ™ manual and automated workflows.
Performed alcohol precipitation on samples for purification.
Conducted PCR using the Applied Biosystems™ QuantStudio™ 5 Real-time PCR system.
Enhanced detection rates of mycoplasma using both workflows.
Automated techniques showed improvements in processing time.
Real-time PCR provided reliable and quantifiable results.

Implication

Research demonstrates rapid mycoplasma detection methods enhance quality in T-cell therapies, suggesting improved safety outcomes.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Min Le (2026) studied this question.

synapsesocial.com/papers/69a67dd6f353c071a6f09d1a https://doi.org/10.5731/pdajpst.2026.26121

View Full Paper

Ask AI

Bookmark

Share

Rapid Mycoplasma Detection Techniques for Facilitating Quality in Low-Volume T-Cell Therapies

Key Points

Implication

Discussion

Cite This Study

Rapid Mycoplasma Detection Techniques for Facilitating Quality in Low-Volume T-Cell Therapies

Key Points

Implication

Discussion

Cite This Study

Keep reading

Keep reading